↓ Skip to main content

Cochrane Database of Systematic Reviews

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, November 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

twitter
10 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
225 Mendeley
Title
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
Published in
Cochrane database of systematic reviews, November 2020
DOI 10.1002/14651858.cd013516.pub2
Pubmed ID
Authors

Emil Ørskov Ipsen, Kasper S Madsen, Yuan Chi, Ulrik Pedersen-Bjergaard, Bernd Richter, Maria-Inti Metzendorf, Bianca Hemmingsen

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 225 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 41 18%
Student > Bachelor 39 17%
Unspecified 20 9%
Researcher 15 7%
Student > Doctoral Student 11 5%
Other 35 16%
Unknown 64 28%
Readers by discipline Count As %
Medicine and Dentistry 68 30%
Nursing and Health Professions 23 10%
Unspecified 20 9%
Psychology 5 2%
Biochemistry, Genetics and Molecular Biology 4 2%
Other 27 12%
Unknown 78 35%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2022.
All research outputs
#4,398,329
of 22,163,477 outputs
Outputs from Cochrane database of systematic reviews
#6,806
of 12,198 outputs
Outputs of similar age
#135,382
of 502,648 outputs
Outputs of similar age from Cochrane database of systematic reviews
#37
of 43 outputs
Altmetric has tracked 22,163,477 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,198 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.9. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 502,648 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.